sulforaphane has been researched along with Fuchs' Endothelial Dystrophy in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Fuchs' Endothelial Dystrophy: Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ziaei, A | 1 |
| Schmedt, T | 1 |
| Chen, Y | 1 |
| Jurkunas, UV | 1 |
1 other study available for sulforaphane and Fuchs' Endothelial Dystrophy
| Article | Year |
|---|---|
Sulforaphane decreases endothelial cell apoptosis in fuchs endothelial corneal dystrophy: a novel treatment.
Topics: Aged; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Cell Line; Corneal Transplantation; End | 2013 |